Eye test and blood markers could spot dangerous pregnancy condition earlier

NCT ID NCT06122220

First seen Jul 16, 2026 · Last updated Jul 17, 2026 · Updated 1 time

Summary

This study looks at whether measuring the optic nerve sheath (the lining around the nerve connecting the eye to the brain) combined with blood tests for angiogenic factors can better diagnose severe pre-eclampsia in pregnant women. Pre-eclampsia is a serious condition that can harm both mother and baby. The researchers will measure these markers in 200 pregnant women between 24 and 40 weeks of pregnancy to see if they can predict complications like organ damage or poor fetal growth.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Measurement of optic nerve sheath diameter and sFLT-1/PIGF index
What this could lead to
If successful, this approach could help doctors more accurately diagnose severe pre-eclampsia and predict complications, potentially improving outcomes for mothers and babies.
What could go wrong
This is an early-stage diagnostic study with 200 participants, so results may not apply to all pregnant women. The measurements may not be precise enough to change clinical practice.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PRE-ECLAMPSIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Saint Thomas Hospital

    Panama City, Provincia de Panamá, Panama

More trials for these conditions

Other studies related to the condition(s) this trial covers.